| Name | chloroprocaine hydrochloride |
|---|---|
| Synonyms |
NESACAINE-MPF
4-amino-2-chlorobenzoate de 2-(diéthylamino)éthyle chlorhydrate 2-diethylaminoethyl 4-amino-2-chlorobenzoate hydrochloride Benzoic acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl ester, hydrochloride (1:1) 2-(Diethylamino)ethyl 4-amino-2-chlorobenzoate hydrochloride (1:1) 2-(Diethylamino)ethyl-4-amino-2-chlorbenzolcarboxylathydrochlorid 2-Chloro-4-aminobenzoic Acid Diethylaminoethyl Ester Hydrochloride 4-Amino-2-chlorobenzoic Acid 2-(Diethylamino)ethyl Ester Monohydrochloride CHLOROPROCAINE HCL Chloroprocaine Hydrochloride 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate,hydrochloride UNII-LT7Z1YW11H Nesacaine Chlorprocainchlorid |
| Description | Chloroprocaine hydrochloride (2-Chloroprocaine hydrochloride) is a potent inhibitor of Na,K-ATPase activity with an IC50 of 13 mM. Chloroprocaine hydrochloride blocks peripheral nerve[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 13 mM (Na,K-ATPase)[1] |
| In Vivo | In mice, the intravenous LD50 of Chloroprocaine hydrochloride is 97 mg/kg and the subcutaneous LD50 of Chloroprocaine hydrochloride is 950 mg/kg[1]. |
| References |
| Boiling Point | 402.6ºC at 760 mmHg |
|---|---|
| Melting Point | 176ºC |
| Molecular Formula | C13H20Cl2N2O2 |
| Molecular Weight | 307.216 |
| Exact Mass | 306.090179 |
| PSA | 41.57000 |
| LogP | 3.62590 |
| Storage condition | -20℃ |
| Stability | Stable. Incompatible with strong oxidizing agents. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| RIDADR | NONH for all modes of transport |
|---|
| Precursor 2 | |
|---|---|
| DownStream 0 | |